Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsVAGINALGeneric

DELFEN

NONOXYNOL-9

Standard Dose
12.5%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview DELFEN is listed in Drugs@FDA under application 014349 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient NONOXYNOL-9 Form and strength AEROSOL;VAGINAL - 12.5% Sponsor PERSONAL PRODS Submission history Latest submission status date: 1989-03-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview DELFEN is listed in Drugs@FDA under application 014349 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient NONOXYNOL-9 Form and strength AEROSOL;VAGINAL - 12.5% Sponsor PERSONAL PRODS Submission history Latest submission status date: 1989-03-27 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.